Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept.

Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, Thiesen HJ (2008) Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept. Arthritis Res Ther 10(3), R50. PubMed

Abstract

About 30% of rheumatoid arthritis patients fail to respond adequately to TNFalpha-blocking therapy. There is a medical and socioeconomic need to identify molecular markers for an early prediction of responders and nonresponders.

Involved Units and Groups

Systems Biology and Bioinformatics

HKI-Authors

Prof. Dr. Reinhard Guthke Dr. Michael Hecker

Topics

Management of heterogeneous experimental data

Identifier

doi: 10.1186/ar2419 PMID: 18454843